Liu Y - Search Results

1

Proguanil inhibits proliferation and migration in glioblastoma development through targeting CSF1R receptor.

Ren B, Liang J, Liu Y, Zhang Y, Ma X, Lei P, Gao J, Ma W. Ren B, et al. Among authors: liu y. Cell Signal. 2024 Dec 9;127:111550. doi: 10.1016/j.cellsig.2024.111550. Online ahead of print. Cell Signal. 2024. PMID: 39662608

2

ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling.

Liu YH, Zhu M, Lei PP, Pan XY, Ma WN. Liu YH, et al. Oncol Rep. 2021 Jul;46(1):136. doi: 10.3892/or.2021.8087. Epub 2021 May 26. Oncol Rep. 2021. PMID: 34036393 Free PMC article.

3

β₂-adrenergic receptor affinity chromatography with an interaction force analysis model: A method for analysis of active compounds targeting β₂-adrenergic receptor.

Ma W, Yang L, Liu Y, Lei P, Zhang Y. Ma W, et al. Among authors: liu y. J Chromatogr A. 2021 Aug 30;1652:462371. doi: 10.1016/j.chroma.2021.462371. Epub 2021 Jun 29. J Chromatogr A. 2021. PMID: 34242937

4

Antiviral drugs suppress infection of 2019-nCoV spike pseudotyped virus by interacting with ACE2 protein.

Wang J, Zhang Y, Hu S, Bai H, Xue Z, Liu Y, Ma W. Wang J, et al. Among authors: liu y. J Biochem Mol Toxicol. 2022 Feb;36(2):e22948. doi: 10.1002/jbt.22948. Epub 2021 Nov 10. J Biochem Mol Toxicol. 2022. PMID: 34755435 Free PMC article.

5

ND-16: A Novel Compound for Inhibiting the Growth of Cutaneous T Cell Lymphoma by Targeting JAK2.

Zhu M, Liu Y, Lei P, Shi X, Tang W, Huang X, Pan X, Wang C, Ma W. Zhu M, et al. Among authors: liu y. Curr Cancer Drug Targets. 2022;22(4):328-339. doi: 10.2174/1568009622666220225121009. Curr Cancer Drug Targets. 2022. PMID: 35220934

6

Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.

Ma W, Liu Y, Lei P, Zhu M, Pan X. Ma W, et al. Among authors: liu y. Curr Cancer Drug Targets. 2022;22(5):404-413. doi: 10.2174/1568009622666220304202116. Curr Cancer Drug Targets. 2022. PMID: 35249489

7

Thebaine induces anaphylactic reactions via the MRGPRX2 receptor pathway on mast cells.

Lei P, Liu Y, Ding Y, Su X, Liang J, Chen H, Ma W. Lei P, et al. Among authors: liu y. Cell Immunol. 2022 May;375:104514. doi: 10.1016/j.cellimm.2022.104514. Epub 2022 Apr 2. Cell Immunol. 2022. PMID: 35398603

8

[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling.

Liu YH, Zhu M, Lei PP, Pan XY, Ma WN. Liu YH, et al. Oncol Rep. 2023 May;49(5):81. doi: 10.3892/or.2023.8518. Epub 2023 Mar 10. Oncol Rep. 2023. PMID: 36896777 Free PMC article.

9

Discovery of Novel p53-MDM2 Inhibitor (RG7388)-Conjugated Platinum^IV Complexes as Potent Antitumor Agents.

Liu W, Ma Y, He Y, Liu Y, Guo Z, He J, Han X, Hu Y, Li M, Jiang R, Wang S. Liu W, et al. Among authors: liu y. J Med Chem. 2024 Jun 13;67(11):9645-9661. doi: 10.1021/acs.jmedchem.4c00784. Epub 2024 May 22. J Med Chem. 2024. PMID: 38776419

10

Discovery of 3-amide-pyrimidine-based derivatives as potential fms-like tyrosine receptor kinase 3 (FLT3) inhibitors for treating acute myelogenous leukemia.

Liu W, Ma Y, Wang M, He Y, Liu Y, Zhu Z, Ding Y, Zhang G, Wang S. Liu W, et al. Among authors: liu y. Bioorg Med Chem Lett. 2024 Dec 19;117:130082. doi: 10.1016/j.bmcl.2024.130082. Online ahead of print. Bioorg Med Chem Lett. 2024. PMID: 39708925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,193 results

Search Page

Filters